Recent Blog Articles

Can long COVID affect the gut?

When replenishing fluids, does milk beat water?

Safe, joyful movement for people of all weights

Slowing down racing thoughts

Are women turning to cannabis for menopause symptom relief?

3 ways to create community and counter loneliness

Helping children make friends: What parents can do

Can electrical brain stimulation boost attention, memory, and more?

Palliative care frightens some people: Here’s how it helps

Parents don't always realize that their teen is suicidal
Harvard Health Blog
Read the latest posts from experts at Harvard Health Publishing covering a variety of health topics and perspectives on medical news.
Articles
Promising technologies for the treatment of prostate cancer
Marc B. Garnick, M.D., provides an overview of possible treatments that need more study, including cryotherapy, HIFU, and focal therapies.
How to handle a relapse after treatment for prostate cancer
Marc B. Garnick, M.D., discusses what biochemical recurrence means and what your options are.
Possible complications of hormone therapy
Three Harvard-affiliated physicians discuss the impact that hormone therapy can have on bones and cardiovascular health.
Intermittent hormone therapy for prostate cancer
Marc B. Garnick, M.D., discusses this therapy, which aims to strike a balance between effective treatment and quality of life.
Hormone therapy for prostate cancer
Marc Garnick, M.D., Editor in Chief of the Annual Report on Prostate Diseases, discusses what you need to know about therapy: when it’s used, what your options are, and what doctors disagree about.
When to consider active surveillance
Which men are candidates for active surveillance? Some studies suggest that men with low risk cancer should consider active surveillance over traditional treatment, but the evidence is mixed.
Early-stage prostate cancer: Treat or wait?
When it comes to early-stage prostate cancer, there is no evidence that one treatment is better than another or that any treatment at all actually prolongs life. If you are diagnosed with early-stage prostate cancer, you’ll want to consider factors such as your values, your quality of life, and the potential side effects of various treatments before making a decision.
Getting a closer look at prostate cancer with molecular imaging
Molecular imaging may help determine the location and extent of cancer — and point to the best treatment — especially metastatic cancers too small to be detected by CT or MRI scanning.
Understanding your prostate pathology report
Not all pathology reports are created equal. In fact, they can vary widely even within a single institution. Learn what your report should contain, what it means, and why asking questions about it can lead to better care.
Improved magnetic resonance imaging (MRI) may aid detection of prostate cancer
Dr. Neil Rofsky, of Harvard’s Beth Israel Deaconess Medical Center, discusses MRI technology, which patients might benefit from it, and the relative advantages and disadvantages of MRI as compared with other imaging modalities.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!